NEW DELHI, India – India's drugs standards regulatory authority has recommended the introduction of a track and trace system for the top 300 pharmaceutical brands sold by 66 companies, in a bid to curb the sale of counterfeit or substandard drugs in the country.
NEW DELHI, India – India's drugs standards regulatory authority has recommended the introduction of a track and trace system for the top 300 pharmaceutical brands sold by 66 companies, in a bid to curb the sale of counterfeit or substandard drugs in the country.
NEW DELHI, India – The World Bank and India have signed a $125 million loan agreement in April, under which the former pledged to support India's national initiative toward innovative biopharmaceuticals and medical devices.
NEW DELHI, India – The World Bank and India have signed a $125 million loan agreement in April, under which the former pledged to support India's national initiative toward innovative biopharmaceuticals and medical devices.
NEW DELHI – India's drug quality administration is cracking down on companies that manufacture and sell unauthorized and untested fixed-dose combination (FDC) drugs, following recent inspections that brought that issue into the spotlight.
NEW DELHI – India's drug quality administration is cracking down on companies that manufacture and sell unauthorized and untested fixed-dose combination (FDC) drugs, following recent inspections that brought that issue into the spotlight.
HYDERABAD, India – India's drug regulator is working to launch this month a new unit that would facilitate access to regulatory information and, hopefully, shore up the willingness of Indian drug companies to take more risks.
